Urgent Meds

Atriance (Nelarabine)

  • Name: Atriance
  • Generic Name: Nelarabine
  • Strength: 250 mg/50 ml (5 mg/ml) Vial.
  • Manufactured : Novartis Pharmaceuticals

Atriance is a nucleoside metabolic inhibitor used for the treatment of patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma whose disease has not responded to or has relapsed after treatment with at least two chemotherapy regimens.

Note: Atriance (Nelarabine) is an FDA approved drug.

Contact Patient Support

If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.

Disclaimer

All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.